Artificial intelligence-driven natural language processing for identifying linguistic patterns in Alzheimer's disease and mild cognitive impairment: A study of lexical, syntactic, and cohesive features of speech through picture description tasks.

Journal: Journal of Alzheimer's disease : JAD
Published Date: May 7, 2025

Abstract

BackgroundLanguage deficits often occur early in the neurodegenerative process, yet traditional methods frequently fail to detect subtle changes. Natural language processing (NLP) offers a novel approach to identifying linguistic patterns associated with cognitive impairment.ObjectiveWe aimed to analyze linguistic features that differentiate cognitively unimpaired (CU), mild cognitive impairment (MCI), and Alzheimer's disease (AD) groups.MethodsData was extracted from picture description tasks performed by 336 participants in the DementiaBank datasets. 53 linguistic features aggregated into 4 categories: lexical, structural, syntactic, and discourse domains, were identified using NLP toolkits. With normal diagnostic cutoffs, cognitive function was evaluated with the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA).ResultsWith age and education as covariates, ANOVA and post-hoc Tukey's HSD tests revealed that linguistic features such as pronoun usage, syntactic complexity, and lexical sophistication showed significant differences between CU, MCI, and AD groups (p < 0.05). Notably, past tense and personal references were higher in AD than both CU and MCI (p < 0.001), while pronoun usage differed between AD and CU (p < 0.0001). Correlations indicated that higher pronoun rates and lower syntactic complexity were associated with lower MMSE scores and although some features like conjunctions and determiners approached significance, they lacked consistent differentiation.ConclusionsWith the growing adoption of artificial intelligence (AI)-based scribing, these results emphasize the potential of targeted linguistic analysis as a digital biomarker to enable continuous screening for cognitive impairment.

Authors

  • Cynthia A Nyongesa
    Alzheimer's Disease Cooperative Study (ADCS), Department of Neurosciences, University of California, San Diego, CA, USA.
  • Mike Hogarth
    Division of Biomedical Informatics, Department of Medicine, University of California, San Diego, CA, USA.
  • Judy Pa
    Alzheimer's Disease Cooperative Study (ADCS), Department of Neurosciences, University of California, San Diego, CA, USA.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals